Document Detail


Insulin-like growth factor-II is a substrate for dipeptidylpeptidase I (cathepsin C). Biological properties of the product.
MedLine Citation:
PMID:  7957246     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We observed that the lysosomal enzyme, dipeptidylaminopeptidase I (DAP-I) caused the release of trichloroacetic-acid-soluble radioactivity from rat 125I-insulin-like growth factor-II (IGF-II). This activity could be blocked by dipeptide inhibitors of DAP-I, and was enhanced by chloride. Treatment of unlabeled rat IGF-II with DAP-I converted approximately 50% of the IGF-II to a species with a slightly shorter elution time on reverse-phase HPLC, whereas treatment of human IGF-II caused complete conversion to the species with the shorter elution time. Rat IGF-II purified from the rat BRL 3A cell line is a mixture of two molecules beginning with Ala-Tyr-Arg-Pro-Ser- and Tyr-Arg-Pro-Ser- [Marquardt, H., Todaro, G. J., Henderson, L. E. & Oroszlan, S. (1981) J. Biol. Chem. 256, 6859-6865] while human IGF-II begins with Ala-Tyr-Arg-Pro-Ser-. Determination of the N-terminal amino acid sequence of human IGF-II before and after digestion with DAP-I showed that DAP-I cleaved Ala-Tyr, terminating at Arg-Pro-; the rat IGF-II species beginning with Tyr-Arg-Pro-Ser- was resistant to digestion. In order to compare DAP-I-treated IGF-II with native IGF-II for binding to IGF receptors and IGF-binding proteins and in a bioassay, rat and human IGF-II were treated with DAP-I and the digested and undigested species were isolated by reverse-phase HPLC. The IGF-II/mannose 6-phosphate receptor was purified from rat placental membranes, the IGF-I receptor was solubilized from human placental membranes and IGF-binding proteins were partially purified from adult and three-day-old rat sera by sequential gel filtration on Sephadex G-200 (pH 8.0) and Sephadex G-50 (acid pH). The dose/response curves of the two IGF-II species were indistinguishable in radioreceptor assays utilizing the IGF-II/mannose 6-phosphate receptor and the IGF-I receptor and in IGF competitive binding assays utilizing partially purified IGF-binding proteins. The DAP-I-digested and native IGF-II species were also equipotent in stimulating [3H]thymidine incorporation into DNA in the human osteosarcoma cell line, MG-63. We conclude that DAP-I cleaves an N-terminal dipeptide from IGF-II and that this does not result in a change in the biological activity of the molecule.
Authors:
W Kiess; C Terry; W H Burgess; B Linder; W Lopaczynski; P Nissley
Related Documents :
2666066 - Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsuli...
8708556 - Plasma clearance and tissue distribution of labelled chicken and human igf-i and igf-ii...
8817666 - Functions and regulation of the acid-labile subunit of the 150 k complex.
10905386 - Effect of exercise training on erythrocyte insulin-like growth factor-i receptor bindin...
14988396 - Crystal structure of kinesin regulated by ca(2+)-calmodulin.
10212286 - Bidirectional transmembrane modulation of integrin alphaiibbeta3 conformations.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of biochemistry / FEBS     Volume:  226     ISSN:  0014-2956     ISO Abbreviation:  Eur. J. Biochem.     Publication Date:  1994 Nov 
Date Detail:
Created Date:  1994-12-28     Completed Date:  1994-12-28     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0107600     Medline TA:  Eur J Biochem     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  179-84     Citation Subset:  IM    
Affiliation:
Metabolism Branch, National Cancer Institute, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amino Acid Sequence
Animals
Cathepsin C
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases / metabolism*
Humans
Hydrolysis
Insulin-Like Growth Factor II / metabolism*
Molecular Sequence Data
Rats
Substrate Specificity
Chemical
Reg. No./Substance:
67763-97-7/Insulin-Like Growth Factor II; EC 3.4.14.-/Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; EC 3.4.14.1/Cathepsin C

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Purification and characterization of the 30S ribosomal proteins from the bacterium Thermus thermophi...
Next Document:  Purification and characterization of coenzyme F390 synthetase from Methanobacterium thermoautotrophi...